Clinical Development Stocks List

Clinical Development Stocks Recent News

Date Stock Title
May 10 AXSM Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments
May 9 ATRA Atara Biotherapeutics GAAP EPS of -$0.23 beats by $0.02, revenue of $27.36M beats by $2.67M
May 9 ATRA Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
May 9 ATRA Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
May 9 AXSM Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 9 AUPH Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
May 8 AXSM Axsome Therapeutics to Present at Upcoming Investor Conferences
May 7 AXSM Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
May 7 AXSM Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
May 7 AUPH How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
May 7 ALNY Alnylam Issues 2023 Corporate Responsibility Report
May 7 AUPH Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
May 7 AXSM Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
May 7 AXSM Q1 2024 Axsome Therapeutics Inc Earnings Call
May 6 AXSM Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
May 6 AXSM Axsome Therapeutics, Inc. (AXSM) Q1 2024 Earnings Call Transcript
May 6 AXSM Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M
May 6 AXSM Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 5 ALNY The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 4 BBIO What You Need To Know About The BridgeBio Pharma, Inc. (NASDAQ:BBIO) Analyst Downgrade Today
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags